Cencora 

$363.42
325
+$4.2+1.17% 今天

統計

當日最高
364.27
當日最低
356.87
52週高點
377.54
52週低點
237.71
成交量
663,215
平均成交量
1,418,216
市值
70.5B
本益比
34.72
股息殖利率
0.67%
股息
2.43

即將到來

股息

0.67%股息殖利率
Mar 26
$0.6
Dec 25
$0.6
Sep 25
$0.55
Jun 25
$0.55
Mar 25
$0.55
10年成長
5.65%
5年成長
6.16%
3年成長
6.89%
1年成長
6.67%

財報

4Feb預期
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
下一步
3.22
3.62
4.02
4.42
預期EPS
4.048801
實際EPS
不適用

財務

0.48%利潤率
有盈利
2020
2021
2022
2023
2024
2025
642.67B營收
3.11B淨利

分析師評級

$401.20平均目標價
最高預估為 440.00。
來自過去6個月內的 10 則評分。這不是投資建議。
買入
90%
持有
10%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 COR 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Show more...
執行長
Dr. Robert P. Mauch Ph.D., PharmD
員工
42000
國家
US
ISIN
US03073E1055

上市

0 Comments

分享你的想法

FAQ

Cencora 今天的股價是多少?
COR 目前價格為 $363.42 USD,過去 24 小時上漲了 +1.17%。在圖表上更密切關注 Cencora 股價表現。
Cencora 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Cencora 的股票以代號 COR 進行交易。
Cencora 的股價在上漲嗎?
COR 股票較上週上漲 +2.33%,本月上漲 +7.36%,過去一年 Cencora 上漲 +43.11%。
Cencora 的市值是多少?
今天 Cencora 的市值為 70.5B
Cencora 下一次財報日期是什麼時候?
Cencora 將於 February 04, 2026 公布下一次財報。
Cencora 上一季度的財報如何?
COR 上一季度的財報為每股 3.84 USD,預估為 3.79 USD,帶來 +1.41% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Cencora 去年的營收是多少?
Cencora 去年的營收為 642.67BUSD。
Cencora 去年的淨利是多少?
COR 去年的淨收益為 3.11BUSD。
Cencora 會發放股息嗎?
是的,COR 的股息每 每季 發放一次。每股最新股息為 0.6 USD。截至今日,股息殖利率(FWD)% 為 0.67%。
Cencora 有多少名員工?
截至 February 02, 2026,公司共有 42,000 名員工。
Cencora 位於哪個產業?
Cencora從事於Health Care產業。
Cencora 何時完成拆股?
Cencora 上次拆股發生於 June 16, 2009,比例為 2:1。
Cencora 的總部在哪裡?
Cencora 的總部位於 US 的 Conshohocken。